Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Bibliographic Details
Published in:	Kidney International Reports
Main Authors:	Lisa Daniel-Fischer, Marlies Antlanger, Daniel Cejka, Kathrin Eller, Philipp Gauckler, Balazs Odler, Michael Rudnicki, Marcus D. Säemann, Alice Schmidt, Gere Sunder-Plassmann, Martin Wiesholzer, Martin Windpessl, Emanuel Zitt, Franz Koenig, Larry A. Greenbaum, Andreas Kronbichler, Christoph Aufricht
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Subjects:	clopidogrel drug repurposing FSGS proteinuria
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024923015693

Similar Items

A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic Associations
by: Marco Bonilla, et al.
Published: (2024-06-01)

Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis
by: Natasha de Zoysa, et al.
Published: (2024-03-01)

Focal Segmental Glomerulosclerosis and Recurrence in Living Donor Recipients
by: Mang J, et al.
Published: (2021-07-01)

A new index for the outcome of focal segmental glomerulosclerosis
by: Liu Chan, et al.
Published: (2024-04-01)

Identification of Pathogenic Pathways for Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation
by: Sahra Pajenda, et al.
Published: (2024-07-01)

Ferroptosis-related genes, a novel therapeutic target for focal segmental glomerulosclerosis
by: Yanbin Lin, et al.
Published: (2024-02-01)

Focal Segmental Glomerulosclerosis caused by Hepatitis B Infection Comorbid with HIV Infection
by: Nicholas Wijayanto, et al.
Published: (2022-09-01)

Focal and Segmental Glomerulosclerosis: A Comprehensive State-of-the-Art Review
by: Dearbhail Ni Cathain, et al.
Published: (2025-07-01)

Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis
by: Yan-Pei Hou, et al.
Published: (2022-01-01)

Familial Focal Segmental Glomerulosclerosis With Late-Onset Presentation and R229Q/R291W Podocin Mutations
by: Michelle T. P. Riguetti, et al.
Published: (2020-09-01)

Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
by: Quynh Tran Thuy Huong, et al.
Published: (2025-01-01)

Collapsing Focal Segmental Glomerulosclerosis in Siblings With Compound Heterozygous Variants in NUP93 Expand the Spectrum of Kidney Phenotypes Associated With Nucleoporin Gene Mutations
by: Rachel K. Cason, et al.
Published: (2022-07-01)

Phellinus igniarius ameliorates renal aging in a rat model of focal and segmental glomerulosclerosis
by: Zhou-Ting Wang, et al.
Published: (2023-01-01)

Clinical and histopathological characteristics of primary focal segmental glomerulosclerosis in Turkish adults
by: Ilhan Kurultak, et al.
Published: (2024-03-01)

Novel variant in MYH9 in a child with proteinuria and thrombocytopenia: a case report and literature review
by: Dan-Feng Xie, et al.
Published: (2025-05-01)

Comparison and prognostic analysis of focal segmental glomerulosclerosis patients with or without nephrotic syndrome at onset
by: Liangliang Chen, et al.
Published: (2025-07-01)

A polymeric dexamethasone prodrug attenuates focal segmental glomerulosclerosis (FSGS) in an Adriamycin-induced mouse model with minimal glucocorticoid side effects
by: Haochen Jiang, et al.
Published: (2025-03-01)

Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis
by: Giuseppe Salfi, et al.
Published: (2023-09-01)

Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome
by: Seoyun Jang, et al.
Published: (2022-10-01)

Refining the adriamycin‐induced focal segmental glomerulosclerosis mouse model to improve reproducibility and animal welfare
by: Haochen Jiang, et al.
Published: (2025-05-01)

Pemphigus vulgaris and focal segmental glomerulosclerosis (FSGS): First reported case and a review of the literature
by: Afsaneh Sadeghzadeh‐Bazargan, et al.
Published: (2023-07-01)

Automation and Decision Support in Nephrology: An Expert System Based on AI and ML for the Assessment, Treatment, and Management of Focal Segmental Glomerulosclerosis
by: Dawid Pawuś, et al.
Published: (2025-01-01)

Terapia della sindrome nefrosica idiopatica: ruolo delle tecniche aferetiche
by: Luigi Moriconi
Published: (2013-07-01)

Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety
by: Kirk N. Campbell, et al.
Published: (2024-06-01)

A clinical case of using therapeutic plasma exchange for the treatment of recurrent focal segmental glomerulosclerosis in a child after kidney transplantation
by: I. A. Miloserdov, et al.
Published: (2021-07-01)

Two Children With Steroid-Resistant Significant Proteinuria Due to Nonsense Mutations of the TRIM8 Gene: A Case Report and Literature Review
by: Xiaojie Li, et al.
Published: (2022-07-01)

Primary Focal Segmental Glomerulosclerosis: Why Are Pieces of This Puzzle Still Missing?
by: Hernán Trimarchi
Published: (2015-07-01)

Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report
by: Ratna Acharya, et al.
Published: (2021-11-01)

The epidemiology of primary FSGS including cluster analysis over a 20-year period
by: Thomas McDonnell, et al.
Published: (2023-12-01)

Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation
by: Ge Y, et al.
Published: (2025-02-01)

Focal Segmental Glomerulosclerosis With Superimposed Infection‐Related Glomerulonephritis in a Diabetic Patient: A Case of Rapid Renal Decline
by: Mahyar Toofantabrizi, et al.
Published: (2024-11-01)

Beyond Antibodies in Post-Transplant FSGS: New Answers or Recurrent Questions?
by: João Venda, et al.
Published: (2025-09-01)

Lysosome stress response and mitochondria injury are the earliest detectable alteration in FSGS
by: Eileen Dahlke, et al.
Published: (2025-10-01)

The predictive value of suPAR for glomerular segmental sclerosis lesions in renal pathology
by: Zurong Zhang, et al.
Published: (2025-12-01)

Hearing Loss Due to Cyclosporine In Children
by: Syed Sajid Hussain Shah
Published: (2023-01-01)

METTL10 attenuates adriamycin-induced podocyte injury by targeting cell dedifferentiation
by: Jiwen Bao, et al.
Published: (2025-01-01)

A Successfully Treated Case of Recurrent Focal Segmental Glomerulosclerosis (FSGS) with Plasmapheresis and High dose Methylprednisolone Pulse Therapy
by: Sun Mi Her, et al.
Published: (2017-10-01)

Functional analysis of heterozygous variants in the SALL1 gene in 2 children with Townes-Brocks syndrome with FSGS
by: Rong Liang, et al.
Published: (2025-02-01)

Efficacy of extracorporeal plasma therapy for adult native kidney patients with Primary FSGS: a Systematic review
by: Jing Miao, et al.
Published: (2023-12-01)

Bioinformatic identification of COLEC12 as a diagnostic biomarker and risk factor in pediatric FSGS
by: Lei Gao, et al.
Published: (2025-04-01)